Zika virus tied to heart problems in adults | US sodium intake increases, study data show | Overweight, obese adults have higher heart disease risks
March 16, 2017
PCNA SmartBrief
News about cardiovascular disease prevention and management
Heart Health News
Zika virus tied to heart problems in adults
The Zika virus has been linked to the development of severe heart conditions, including heart rhythm disorders and heart failure, among nine adults in Venezuela, according to a study to be presented at the annual meeting of the American College of Cardiology. The patients were treated for heart symptoms that began about 10 days after infection, and the only history of heart-related conditions among the nine was a case of well-controlled high blood pressure.
HealthDay News (3/9),  The Associated Press (3/9) 
LinkedIn Twitter Facebook Google+ Email
US sodium intake increases, study data show
Data on more than 13,000 adults with high blood pressure showed that between 1999 and 2012 sodium intake increased from about 2,900 milligrams daily to 3,350 mg/day, according to a study to be presented at the American College of Cardiology's annual meeting. The study found sodium consumption increased more than 14% among people with hypertension, 26% among Hispanics, 20% among blacks and 2% among whites.
HealthDay News (3/8) 
LinkedIn Twitter Facebook Google+ Email
Overweight, obese adults have higher heart disease risks
Study data show overweight and obese middle-age women and obese middle-age men developed heart disease sooner than their normal-weight counterparts, researchers told an American Heart Association meeting. The study found overweight and obese adults had a higher lifetime risk for developing heart disease, compared with people who had a normal BMI.
HealthDay News (3/9) 
LinkedIn Twitter Facebook Google+ Email
Other News
CCNE accredited RN to BS in Nursing Online
A BS in Nursing opens new opportunities to advance your career! Choose a flexible, online, CCNE accredited program that fits your work/life balance and is highly recommended by alumni & employers. Affordable tuition, full tech & student support. Start the Journey!
Emerging Trends
Long-term data support safety, effectiveness of PCSK9 inhibitor
A study in JAMA Cardiology found the median low-density lipoprotein reduction from taking the PCSK9 inhibitor evolocumab over 44 months was 57%, compared with 61% at 12 months. A second study in the journal found long-term use of the drug did not increase the frequency of adverse events and reduced the risk of cardiac events.
MedPage Today (free registration) (3/15) 
LinkedIn Twitter Facebook Google+ Email
Many AF patients who had a stroke lacked preventive therapy
Study data showed 84% of patients with atrial fibrillation were not taking adequate clot-prevention therapy before they had a stroke, researchers reported in the Journal of the American Medical Association. The study included more than 94,000 US patients and found some were not taking any anticoagulant medicine, while others were taking only aspirin or were on an inadequate dosage of warfarin.
HealthDay News (3/14) 
LinkedIn Twitter Facebook Google+ Email
Nursing in the News
Panelists: Nurses' voices needed in health care debate
Panelists at the American Nurses Association's annual conference in Tampa, Fla., called on nurses to be active in the discussion of efforts to repeal and replace the Affordable Care Act by writing letters to lawmakers, speaking out on social media and reaching out to journalists. "This is perfect opportunity for us to position ourselves as the people who know the most about how care is delivered in this country," said Jeffrey Doucette, the vice president of the Magnet Recognition Program and Pathway to Excellence at the American Nurses Credentialing Center.
WUSF-FM (Tampa, Fla.) (3/9) 
LinkedIn Twitter Facebook Google+ Email
PCNA Update
Webcast of the Cardiovascular Nursing Symposium
Can't make the trip to Denver? Enjoy high-quality speakers and cutting-edge content from the comfort of your home or office. The Cardiovascular Nursing Symposium Webcast will give you the option to watch the meeting as it happens or view the recording for three months afterward. Either way, you'll be earning 17.0 hours of CE (including 2.0 hours of pharmacology) while learning the latest in CVD prevention and management ... and no one will see you in your slippers. Learn more and register.
LinkedIn Twitter Facebook Google+ Email
Learn more about PCNA:
Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
Idleness is the beginning of all vice, the crown of all virtues.
Franz Kafka,
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information